0001437749-20-019981.txt : 20200922 0001437749-20-019981.hdr.sgml : 20200922 20200922095654 ACCESSION NUMBER: 0001437749-20-019981 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200922 DATE AS OF CHANGE: 20200922 EFFECTIVENESS DATE: 20200922 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OX2 Therapeutics, Inc. CENTRAL INDEX KEY: 0001704490 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-375949 FILM NUMBER: 201188108 BUSINESS ADDRESS: STREET 1: 16632 IREDALE PATH CITY: LAKEVILLE STATE: MN ZIP: 55044 BUSINESS PHONE: 612-309-7653 MAIL ADDRESS: STREET 1: 16632 IREDALE PATH CITY: LAKEVILLE STATE: MN ZIP: 55044 D 1 primary_doc.xml X0708 D LIVE 0001704490 OX2 Therapeutics, Inc. 1621 E. Hennepin Avenue Suite 290 Minneapolis MN MINNESOTA 55414 612-309-7653 DELAWARE None None Corporation true 2016 Jeff Liter 1621 E. Hennepin Avenue Suite 290 Minneapolis MN MINNESOTA 55414 Executive Officer Promoter Mike Olin 1621 E. Hennepin Avenue Suite 290 Minneapolis MN MINNESOTA 55414 Executive Officer Director Christopher Moertel 1621 E. Hennepin Avenue Suite 290 Minneapolis MN MINNESOTA 55414 Executive Officer Director Rob Parish 1621 E. Hennepin Avenue Suite 290 Minneapolis MN MINNESOTA 55414 Director Andrea Hunt 1621 E. Hennepin Avenue Suite 290 Minneapolis MN MINNESOTA 55414 Director Ben Oehler 1621 E. Hennepin Avenue Suite 290 Minneapolis MN MINNESOTA 55414 Director Biotechnology Decline to Disclose 06b false 2020-08-20 false true false 0 750007 649415 100592 false 15 0 0 0 false OX2 Therapeutics, Inc. /s/ Jeff Liter Jeff Liter President 2020-09-21